NCT02973529View on ClinicalTrials.gov

The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

November 30, 2026

Study Completion Date

September 30, 2028

Conditions
Coronary Artery Disease
Interventions
DEVICE

Absorb

Randomization to implantation of Absorb BVS in bifurcation lesion

DEVICE

Desolve

Randomization to implantation of Desolve BRS in bifurcation lesion

Trial Locations (4)

8200

Aarhus University Hospital, Aarhus N

Unknown

Odense University Hospital, Odense

Zealand University Hospital, Roskilde, Roskilde

Latvian Heart Center, Riga

All Listed Sponsors
lead

Aarhus University Hospital Skejby

OTHER

NCT02973529 - The Bioresorbable Implants for Scaffolding Obstructions in Randomized Bifurcations (BIFSORB) Study | Biotech Hunter | Biotech Hunter